Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | KDM5B | Q9UGL1 | 2/20 | 0.46 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8945534 | 0.85 | TDP1 (0.60) | L3MBTL1NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL27665138 | 0.82 | ESR1 (0.54) | L3MBTL1ESR1ESR2NPC1RAB9A | |
| SCHEMBL9561789 | 0.81 | TSHR (0.47) | NPC1RAB9AALDH1A1CYP3A4TSHR | |
| SCHEMBL19439130 | 0.80 | ESR1 (0.69) | L3MBTL1ESR1ESR2NPC1RAB9A | |
| SCHEMBL27327003 | 0.80 | L3MBTL1 (0.69) | L3MBTL1ESR1ESR2NPC1RAB9A | |
| Bromide SCHEMBL29099292 | 0.79 | ESR1 (0.67) | L3MBTL1ESR1ESR2NPC1RAB9A | |
| SCHEMBL8406007 | 0.79 | JMJD6 (0.59) | L3MBTL1ESR1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8945290 | 0.78 | TDP1 (0.58) | NPC1RAB9ASMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL8945285 | 0.78 | KDM5A (0.56) | SMN1; SMN2ALDH1A1TDP1TSHRKDM5B | |
| SCHEMBL9345772 | 0.78 | SMN1; SMN2 (0.50) | NPC1RAB9ASMN1; SMN2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11045407-B2 | Process for treating keratin fibres with a pyridinedicarboxylic acid compound | L'OREAL (FR) | 2021-06-29 | — | — | US | disclosed |
| US-10857087-B2 | Process for treating keratin fibres with a polysaccharide and a pyridinedi-carboxylic acid compound | L'OREAL (FR) | 2020-12-08 | — | — | US | disclosed |
| WO-2016142635-A1 | METHOD FOR THE COSMETIC TREATMENT OF THICK HAIR WITH A PYRIDINE DICARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2016-09-15 | — | — | WO | disclosed |
| US-20160228346-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2016-08-11 | — | — | US | disclosed |
| US-20160228346-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2016-08-11 | — | — | US | disclosed |
| US-20160213587-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A PYRIDINEDICARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2016-07-28 | — | — | US | disclosed |
| US-20160213587-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A PYRIDINEDICARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2016-07-28 | — | — | US | disclosed |
| WO-2015036476-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2015-03-19 | — | — | WO | disclosed |
| WO-2015036477-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A PYRIDINEDICARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2015-03-19 | — | — | WO | disclosed |
| EP-1911438-A2 | Cosmetic composition containing a derivative of dibenzoylmethane and a arylalkyl amide or ester compound; method of photostabilising the derivative of dibenzoylmethane | L'Oréal (FR) | 2008-04-16 | — | — | EP | disclosed |
| EP-1911438-A2 | Cosmetic composition containing a derivative of dibenzoylmethane and a arylalkyl amide or ester compound; method of photostabilising the derivative of dibenzoylmethane | L'Oréal (FR) | 2008-04-16 | — | — | EP | disclosed |
| US-20080019930-A1 | Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds | L'OREAL (FR) | 2008-01-24 | — | — | US | disclosed |
| US-20080019930-A1 | Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds | L'OREAL (FR) | 2008-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080019930-A1 | Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds | TYR, DDT, AADAC | L3MBTL1 3294/4885ESR1 779/4885ESR2 805/4885 |
| US-11045407-B2 | Process for treating keratin fibres with a pyridinedicarboxylic acid compound | KRT18, CUTA, HKDC1 | L3MBTL1 4850/4885ESR1 4338/4885ESR2 4374/4885 |
| US-20160228346-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND | KRT18, HKDC1, PHYKPL | L3MBTL1 4883/4885ESR1 4541/4885ESR2 4575/4885 |
| US-20160213587-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A PYRIDINEDICARBOXYLIC ACID COMPOUND | KRT18, CUTA, HKDC1 | L3MBTL1 4850/4885ESR1 4338/4885ESR2 4374/4885 |
| US-10857087-B2 | Process for treating keratin fibres with a polysaccharide and a pyridinedi-carboxylic acid compound | KRT18, HKDC1, PHYKPL | L3MBTL1 4883/4885ESR1 4541/4885ESR2 4575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.